This Christmas, Elon Musk flaunted his new body, which he said he achieved with the aid of diabetes medicine.Musk disclosed his metamorphosis on social media and acknowledged using the well-known weight-loss medication Mounjaro.
He captioned the photo: “Ozempic Santa — Like Cocaine Bear, but Santa and Ozempic!”Musk quickly clarified: “Technically, Mounjaro, but that doesn’t have the same ring to it.”
Similar to Ozempic, Mounjaro is a member of the GLP-1 inhibitor medication class.
These drugs, which were first created to help diabetics control their blood sugar and insulin levels, have become more and more well-liked by Americans who want to efficiently reduce their body weight.Musk, 53, stated that he prefers Mounjaro to Ozempic since it has less negative effects.“High doses of [Ozempic] made me fart & burp like Barney from the Simpson’s,” Musk joked, adding: “Mounjaro seems to have fewer side effects and be more effective.”
According to the New York Post, Musk has long pushed for the broad usage of GLP-1 inhibitors to combat the obesity epidemic in the country.But his position stands in stark contrast to that of Robert F. Kennedy Jr., the new secretary of health and human services, who advocates for improved eating habits over medicine.Kennedy, 70, has maintained that altering one’s diet is a more lasting and economical way to combat obesity.As Musk and Kennedy get ready to assume key positions in President-elect Donald Trump’s cabinet, the divergent points of view are anticipated to provoke discussions.Musk will serve as the chairman of the Department of Governmental Efficiency, which was just established.The presenters of The View have even unexpectedly praised Musk for his support of GLP-1 inhibitors.Musk agreed with Whoopi Goldberg, who has been vocal about her use of Mounjaro
Elon’s right on this!” Goldberg said during a recent episode, referencing the disagreement between Musk and Kennedy.Before launching Mounjaro, the 69-year-old comedian weighed close to 300 pounds. She also discussed her personal weight-loss experience with the audience.Goldberg proudly showed off her smaller frame during the conversation.Musk recently endorsed Mounjaro after he acknowledged using Wegovy, another GLP-1 inhibitor, in 2022.
